Biogen Message Board - Msg: 6014989

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 164.63

+1.9%

3:50 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (769)	10/14/1998 1:41:00 PM
From: Hong-Lee Yu	Read Replies (1) of 1686

Harold, I think the stock will go to 70-80 trading ranges very soon. The stock continues to hold its gain even after a huge run. Analysts start to raise the estimates now. I know Goldman Sache raised the EPS in 1999 to 2.50 I will particularly look at the earning report from SGP. Hopefully they will have information regarding Intron-A. My guess is that Intron-A will grow at least 20% over the same quarter in 1997. This will put royalty revenues for BGEN in 45-48M ranges in Q4 (up from 38M in Q3). This, together with 15M increase in Avonex sales (from 107M to 120M), means that BGEN's q4 EPS will be close to 0.60C.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next